register

ESG

Thank you for staying home this Easter from Australia’s blood cancer community

Health Industry Hub | April 14, 2020 |

Leading national blood cancer organisation the Leukaemia Foundation thanks Australians for following the recommended guidelines over the Easter Weekend as it struggles to continue supporting some of the nation’s most vulnerable people in the changing COVID-19 environment.

CEO Bill Petch said people living with blood cancer are faced with the constant challenge of a compromised immune system, and coming into contact with COVID-19 could be tragic.

“Social isolation is not a new concept to Australians living with blood cancer – it is something many of them are forced to do every day to ensure their health and safety. However, COVID-19 has added a new layer of concern for these Australians who are highly vulnerable to infection,” he said.

Mr Petch thanked every Australian who is stayed home and practised social distancing and, in doing so, played their part to keep safe the many children, adults and older Australians living with a blood cancer and helping to ease their anxieties during this unnerving time.

The Leukaemia Foundation is preparing for a shortfall in fundraising this year, with a number of community fundraising events being compromised or cancelled due to COVID-19, and the organisation is now working hard to continue offering vital support in a COVID-19 environment and beyond.

“Blood cancer doesn’t stop – even during a pandemic – and our concern is not only for the safety of our community today, but how we will continue to address the needs of more Australians being diagnosed with blood cancer in the future,” Mr Petch said.

“With 110,000 Australians already living with blood cancer and another 41 Australians diagnosed with the disease every day, the numbers are not in our favour when it comes to stretching our services to support all those in need.

“This week alone, we have had a spike in enquiries from Australians living with blood cancer wanting support and information on accessing their treatment, managing their infection risk and overall emotional support in this distressing time.

“We recognise that every Australian has been affected by the impacts of COVID-19 and we appreciate how difficult the last few weeks and months have been.

“The reality is our organisation is relying now more than ever on the generosity of Australians to help give people living with blood cancer someone to turn to, a place to call home during treatment and access to the best possible care, and we deeply appreciate any support through this time to continue this important work.”

To help support Australians living with blood cancer and ensure they continue to be able to access the support and information they need during the COVID-19 pandemic, the Leukaemia Foundation has launched an Emergency Appeal.


Human Resources

Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day

Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day

Health Industry Hub | May 20, 2024 |

People & Culture: Coinciding with International HR Day, Karen Newell, Senior HR Director for ANZ at Medtronic, joined Health Industry […]

More


News & Trends - MedTech & Diagnostics

Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation

Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation

Health Industry Hub | May 20, 2024 |

MedTech & Diagnostics News: An Australian-based medtech company announced promising results from the first-in-human study for its pulsed field ablation […]

More


News & Trends - MedTech & Diagnostics

Federal budget delivers 'mixed news' for radiologists

Federal budget delivers ‘mixed news’ for radiologists

Health Industry Hub | May 20, 2024 |

MedTech & Diagnostics News: The Royal College of Australian and New Zealand Radiologists (RANZCR) and the Interventional Radiology Society of […]

More


News & Trends - Pharmaceuticals

AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers

AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers

Health Industry Hub | May 20, 2024 |

Pharma News: The Senate Community Affairs References Committee has released its inquiry report into Equitable access to diagnosis and treatment […]

More


This content is copyright protected. Please subscribe to gain access.